서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Publications

Detailed Information

Epstein-Barr virus antibody level and gastric cancer risk in Korea: a nested case-control study

DC Field Value Language
dc.contributor.authorKim, Y.-
dc.contributor.authorShin, A.-
dc.contributor.authorGwack, J.-
dc.contributor.authorKo, K-P-
dc.contributor.authorPark, S. K.-
dc.contributor.authorKang, D.-
dc.contributor.authorYoo, K-Y-
dc.contributor.authorHong, Y-C-
dc.contributor.authorKim, C-S-
dc.date.accessioned2012-06-08T07:49:12Z-
dc.date.available2012-06-08T07:49:12Z-
dc.date.issued2009-07-
dc.identifier.citationBRITISH JOURNAL OF CANCER; Vol.101 3; 526-529ko_KR
dc.identifier.issn0007-0920-
dc.identifier.urihttps://hdl.handle.net/10371/76927-
dc.description.abstractBACKGROUND: Few cohort studies have investigated Epstein-Barr virus (EBV) infection before the occurrence of gastric cancer. METHODS: Among 14 440 cohort participants, 100 incident gastric cancer cases were individually matched to two controls. Epstein-Barr virus antibodies IgG and IgA against viral capsid antigen (VCA), EBV nuclear antigen (EBNA) antibody IgG, and early antigen (EA) antibody IgG were measured using enzyme immunoassays (EIAs). RESULTS: The highest titres of VCA IgG (odds ratio (OR): 1.37, 95% confidence interval (CI): 0.62-3.06) or EBNA IgG (OR: 0.87, 95% CI: 0.51-1.46) were not associated with gastric cancer risk. CONCLUSION: Higher levels of VCA IgG or EBNA IgG were not associated with increased risk of gastric adenocarcinoma in Koreans.ko_KR
dc.language.isoenko_KR
dc.publisherNATURE PUBLISHING GROUPko_KR
dc.subjectstomach neoplasmsko_KR
dc.subjectEpstein-Barr virusko_KR
dc.subjectKoreako_KR
dc.subjectnested case-control studyko_KR
dc.titleEpstein-Barr virus antibody level and gastric cancer risk in Korea: a nested case-control studyko_KR
dc.typeArticleko_KR
dc.identifier.doi10.1038/sj.bjc.6605146-
dc.citation.journaltitleBRITISH JOURNAL OF CANCER-
dc.description.citedreferenceAkiba S, 2008, CANCER SCI, V99, P195, DOI 10.1111/j.1349-7006.2007.00674.x-
dc.description.citedreferenceKoshiol J, 2007, BRIT J CANCER, V97, P1567, DOI 10.1038/sj.bjc.6604063-
dc.description.citedreferenceTedeschi R, 2007, AM J EPIDEMIOL, V165, P134, DOI 10.1093/aje/kwj332-
dc.description.citedreferenceGwack J, 2006, BRIT J CANCER, V95, P639, DOI 10.1038/sj.bjc.6603309-
dc.description.citedreferenceOuburg S, 2005, EUR J GASTROEN HEPAT, V17, P1213-
dc.description.citedreferenceChan D, 2005, J RES PRACT INF TECH, V37, P267-
dc.description.citedreferenceHERRERAGOEPFERT R, 2005, WORLD J GASTROENTERO, V11, P6096-
dc.description.citedreferenceCORREA P, 2004, GASTRIC CANCER, V7, P9-
dc.description.citedreferenceMacsween KF, 2003, LANCET INFECT DIS, V3, P131-
dc.description.citedreferenceGartner BC, 2003, CLIN DIAGN LAB IMMUN, V10, P78, DOI 10.1128/CDLI.10.1.78-82.2003-
dc.description.citedreferenceBurgess DE, 2002, BRIT J CANCER, V86, P702, DOI 10.1038/sj/bjc/6600107-
dc.description.citedreferenceYOO KY, 2002, ASIAN PAC J CANCER P, V3, P85-
dc.description.citedreferenceChien YC, 2001, NEW ENGL J MED, V345, P1877-
dc.description.citedreferenceBruu AL, 2000, CLIN DIAGN LAB IMMUN, V7, P451-
dc.description.citedreferenceShinkura R, 2000, J MED VIROL, V60, P411-
dc.description.citedreferenceAkre O, 1999, INT J CANCER, V82, P1-
dc.description.citedreferenceTokunaga M, 1998, CANCER EPIDEM BIOMAR, V7, P449-
dc.description.citedreference*IARC, 1997, EPSTEINBARR VIR KAP, V8-
dc.description.citedreferenceLEVINE PH, 1995, INT J CANCER, V60, P642-
dc.description.citedreferenceLEHTINEN T, 1993, CANCER CAUSE CONTROL, V4, P187-
dc.description.citedreferenceGESER A, 1982, INT J CANCER, V29, P397-
dc.description.tc0-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

Show Simple Item Record
Find it @ SNU

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share

qrcode
SNS Share